Pfizer Units Escape Suit Over Hormone Treatments

Law360, New York (July 28, 2011, 7:56 PM ET) -- A West Virginia federal jury on Thursday found that hormone therapy treatments made by two Pfizer Inc. subsidiaries did not cause a plaintiff’s breast cancer, siding with the pharmaceutical giant in a case tied to multidistrict litigation over the drugs.

The jury decided in favor of Wyeth Pharmaceuticals Inc. and Pharmacia & Upjohn Co. on all claims brought by plaintiff Leah Royce Hines in the suit she first launched in 2004. Hines alleged that she regularly ingested Wyeth's Premarin and Pharmacia's Provera treatments from 1987 until...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required